US12617785B2 - Pyrrolo[2,3-b]pyridine-3-carboxamide compositions and methods for ameliorating hearing loss - Google Patents
Pyrrolo[2,3-b]pyridine-3-carboxamide compositions and methods for ameliorating hearing lossInfo
- Publication number
- US12617785B2 US12617785B2 US17/760,143 US202117760143A US12617785B2 US 12617785 B2 US12617785 B2 US 12617785B2 US 202117760143 A US202117760143 A US 202117760143A US 12617785 B2 US12617785 B2 US 12617785B2
- Authority
- US
- United States
- Prior art keywords
- alkyl
- mmol
- ethyl
- carbamate
- group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active, expires
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US17/760,143 US12617785B2 (en) | 2020-02-05 | 2021-02-05 | Pyrrolo[2,3-b]pyridine-3-carboxamide compositions and methods for ameliorating hearing loss |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202062970425P | 2020-02-05 | 2020-02-05 | |
| PCT/US2021/016848 WO2021158936A1 (en) | 2020-02-05 | 2021-02-05 | Pyrrolo [2,3-b]pyridine-3-carboxamide compositions and methods for ameliorating hearing loss |
| US17/760,143 US12617785B2 (en) | 2020-02-05 | 2021-02-05 | Pyrrolo[2,3-b]pyridine-3-carboxamide compositions and methods for ameliorating hearing loss |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| US20230137893A1 US20230137893A1 (en) | 2023-05-04 |
| US12617785B2 true US12617785B2 (en) | 2026-05-05 |
Family
ID=77199407
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US17/760,143 Active 2043-05-25 US12617785B2 (en) | 2020-02-05 | 2021-02-05 | Pyrrolo[2,3-b]pyridine-3-carboxamide compositions and methods for ameliorating hearing loss |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US12617785B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4100008B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP7678595B2 (cg-RX-API-DMAC7.html) |
| CN (1) | CN115515579B (cg-RX-API-DMAC7.html) |
| AU (1) | AU2021215925B2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3170121A1 (cg-RX-API-DMAC7.html) |
| ES (1) | ES3025983T3 (cg-RX-API-DMAC7.html) |
| MX (1) | MX428671B (cg-RX-API-DMAC7.html) |
| WO (1) | WO2021158936A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN115515579B (zh) | 2020-02-05 | 2025-09-30 | 洛克菲勒大学 | 吡咯并[2,3-b]吡啶-3-甲酰胺组合物和改善听力损失的方法 |
| EP4380562A4 (en) * | 2021-08-02 | 2025-05-21 | The Rockefeller University | PYRROLOPYRIDINE-3- AND 4-CARBOXAMIDE COMPOSITIONS AND METHODS FOR CELL PROLIFERATION |
| EP4687896A1 (en) * | 2023-04-04 | 2026-02-11 | Children's Hospital Los Angeles | Lats kinase inhibitor to treat retinal degeneration |
| WO2026010871A1 (en) * | 2024-07-01 | 2026-01-08 | Hudspeth A James | ((pyrrolopyridine-3-carbonyl) imino)-2,3-dihydrothiazol-4-yl) methyl phosphates for activating yap |
| KR20260029093A (ko) * | 2024-08-23 | 2026-03-04 | 한국화학연구원 | 카이네이즈 억제제 |
| WO2026043170A1 (ko) * | 2024-08-23 | 2026-02-26 | 한국화학연구원 | 카이네이즈 억제제 |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20070129364A1 (en) | 2005-12-07 | 2007-06-07 | Han-Qing Dong | Pyrrolopyridine kinase inhibiting compounds |
| US20110082144A1 (en) | 2003-11-24 | 2011-04-07 | Transtech Pharma, Inc. | N-heteroaryl indole carboxamides and analogues thereof, for use as glucokinase activators in the treatment of diabetes |
| US20110092538A1 (en) | 2006-12-21 | 2011-04-21 | Plexxikon Inc. | Compounds and methods for kinase modulation, and indications therefor |
| US8592398B2 (en) | 2010-12-20 | 2013-11-26 | Glenmark Pharmaceuticals, S.A. | 2-amino-4-arylthiazole compounds as TRPA1 antagonists |
| WO2021158936A1 (en) | 2020-02-05 | 2021-08-12 | The Rockefeller University | Pyrrolo [2,3-b]pyridine-3-carboxamide compositions and methods for ameliorating hearing loss |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2888848B1 (fr) * | 2005-07-22 | 2007-09-28 | Sanofi Aventis Sa | Derives de n-(arylalkyl)-1h-pyrrrolopyridine-2-carboxamides, leur preparation et leur application en therapeutique |
| TWI667233B (zh) * | 2013-12-19 | 2019-08-01 | 德商拜耳製藥公司 | 新穎吲唑羧醯胺,其製備方法、含彼等之醫藥製劑及其製造醫藥之用途 |
| GB201602854D0 (en) * | 2016-02-18 | 2016-04-06 | Mission Therapeutics Ltd | Novel compounds |
| JOP20190257A1 (ar) * | 2017-04-28 | 2019-10-28 | Novartis Ag | مركبات أريل غير متجانسة ثنائية الحلقة مندمجة 6-6 واستخدامها كمثبطات lats |
-
2021
- 2021-02-05 CN CN202180019399.6A patent/CN115515579B/zh active Active
- 2021-02-05 JP JP2022548109A patent/JP7678595B2/ja active Active
- 2021-02-05 ES ES21750999T patent/ES3025983T3/es active Active
- 2021-02-05 WO PCT/US2021/016848 patent/WO2021158936A1/en not_active Ceased
- 2021-02-05 CA CA3170121A patent/CA3170121A1/en active Pending
- 2021-02-05 EP EP21750999.1A patent/EP4100008B1/en active Active
- 2021-02-05 AU AU2021215925A patent/AU2021215925B2/en active Active
- 2021-02-05 US US17/760,143 patent/US12617785B2/en active Active
- 2021-02-05 MX MX2022009572A patent/MX428671B/es unknown
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20110082144A1 (en) | 2003-11-24 | 2011-04-07 | Transtech Pharma, Inc. | N-heteroaryl indole carboxamides and analogues thereof, for use as glucokinase activators in the treatment of diabetes |
| US20070129364A1 (en) | 2005-12-07 | 2007-06-07 | Han-Qing Dong | Pyrrolopyridine kinase inhibiting compounds |
| US20110092538A1 (en) | 2006-12-21 | 2011-04-21 | Plexxikon Inc. | Compounds and methods for kinase modulation, and indications therefor |
| US8592398B2 (en) | 2010-12-20 | 2013-11-26 | Glenmark Pharmaceuticals, S.A. | 2-amino-4-arylthiazole compounds as TRPA1 antagonists |
| WO2021158936A1 (en) | 2020-02-05 | 2021-08-12 | The Rockefeller University | Pyrrolo [2,3-b]pyridine-3-carboxamide compositions and methods for ameliorating hearing loss |
Non-Patent Citations (14)
| Title |
|---|
| American Chemical Society. Chemical Abstract Service. RN 1942057-09-1. Entered into STN: Jun. 29, 2016. (Year: 2016). * |
| International Search Report and Written Opinion in International Application No. PCT/US2021/016848 mailed Jul. 8, 2021. |
| Kastan et al. "Small-Molecule Inhibition of Lats Kinase Promotes Yap-dependent proliferation in Postmitotic Mammalian Tissues", bioRxiv, Apr. 16, 2020, pp. 1-42. |
| Pubchem CID 154857855, Create date: Dec. 15, 2020 (Dec. 15, 2020), entire document, especially p. 2, compound listed Dec. 15, 2020. |
| Pubchem SID: 438701942 deposited on Dec. 15, 2020, pp. 1-8. pg. 2. |
| Registry No. 1424635-83-5, CAS Registry Apr. 18, 2013. |
| U et al. "Discovery of 4-Substituted Methoxybenzoyl-aryl-thiazole as Novel Anticancer Agents: Synthesis, Biological Evaluation, and Structure-Activity Relationships" J. Med.Chem 52, 1701-1711(2009) 2009. |
| American Chemical Society. Chemical Abstract Service. RN 1942057-09-1. Entered into STN: Jun. 29, 2016. (Year: 2016). * |
| International Search Report and Written Opinion in International Application No. PCT/US2021/016848 mailed Jul. 8, 2021. |
| Kastan et al. "Small-Molecule Inhibition of Lats Kinase Promotes Yap-dependent proliferation in Postmitotic Mammalian Tissues", bioRxiv, Apr. 16, 2020, pp. 1-42. |
| Pubchem CID 154857855, Create date: Dec. 15, 2020 (Dec. 15, 2020), entire document, especially p. 2, compound listed Dec. 15, 2020. |
| Pubchem SID: 438701942 deposited on Dec. 15, 2020, pp. 1-8. pg. 2. |
| Registry No. 1424635-83-5, CAS Registry Apr. 18, 2013. |
| U et al. "Discovery of 4-Substituted Methoxybenzoyl-aryl-thiazole as Novel Anticancer Agents: Synthesis, Biological Evaluation, and Structure-Activity Relationships" J. Med.Chem 52, 1701-1711(2009) 2009. |
Also Published As
| Publication number | Publication date |
|---|---|
| CA3170121A1 (en) | 2021-08-12 |
| AU2021215925B2 (en) | 2026-04-09 |
| JP2023512823A (ja) | 2023-03-29 |
| CN115515579B (zh) | 2025-09-30 |
| EP4100008A1 (en) | 2022-12-14 |
| CN115515579A (zh) | 2022-12-23 |
| US20230137893A1 (en) | 2023-05-04 |
| MX2022009572A (es) | 2022-12-13 |
| WO2021158936A1 (en) | 2021-08-12 |
| EP4100008A4 (en) | 2024-02-07 |
| ES3025983T3 (en) | 2025-06-10 |
| MX428671B (es) | 2025-11-13 |
| AU2021215925A1 (en) | 2022-09-08 |
| JP7678595B2 (ja) | 2025-05-16 |
| EP4100008B1 (en) | 2025-04-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP4100008B1 (en) | Pyrrolo [2,3-b]pyridine-3-carboxamide compositions and methods for ameliorating hearing loss | |
| JP6728208B2 (ja) | ベンザゼピンジカルボキサミド化合物 | |
| ES2893289T3 (es) | Inhibidores de glucosidasa | |
| US11731986B2 (en) | Inhibitors of low molecular weight protein tyrosine phosphatase (LMPTP) and uses thereof | |
| US9181234B2 (en) | Antibacterial compounds | |
| US12534461B2 (en) | Imidazopyridinyl compounds and use thereof for treatment of neurodegenerative disorders | |
| US9346794B1 (en) | Substituted 4-pyridones and their use as inhibitors of neutrophil elastase activity | |
| JP2019532995A (ja) | タウタンパク質標的化protac、および関連使用方法 | |
| WO2018108156A1 (zh) | Rock抑制剂及其应用 | |
| JP2007507549A (ja) | キナーゼ阻害剤としての1,6,7−三置換アザベンゾイミダゾールの調製 | |
| US20180170906A1 (en) | Therapeutic inhibitory compounds | |
| US20080032991A1 (en) | 2, 8-disubstituted Naphthyridine Derivatives | |
| US20240343726A1 (en) | Pyrrolopyridine-3- and 4-carboxamide compositions and methods for cellular proliferation | |
| US11744824B2 (en) | 2-amino-3-carbonyl imidazopyridine and pyrazolopyridine compounds | |
| JP2018503683A (ja) | ピロールアミド系化合物、その製造方法、及び用途 | |
| KR20230129394A (ko) | 리아노딘 수용체를 수반하는 장애를 치료하기 위한 작용제 | |
| CN102933214A (zh) | 可用作二肽基肽酶-1(dpp-1)抑制剂的4,4-二取代的哌啶衍生物 | |
| HK40083035B (en) | Parp7 inhibitor and use thereof | |
| WO2025180442A1 (zh) | Hdac抑制剂及其在医药上的应用 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AS | Assignment |
Owner name: TRI-INSTITUTIONAL THERAPEUTICS DISCOVERY INSTITUTE, INC., NEW YORK Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:HUDSPETH, A. JAMES;KASTAN, NATHANIEL;GNEDEVA, KSENIA;AND OTHERS;SIGNING DATES FROM 20220520 TO 20220616;REEL/FRAME:061034/0332 Owner name: THE ROCKEFELLER UNIVERSITY, NEW YORK Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:HUDSPETH, A. JAMES;KASTAN, NATHANIEL;GNEDEVA, KSENIA;AND OTHERS;SIGNING DATES FROM 20220520 TO 20220616;REEL/FRAME:061034/0332 |
|
| FEPP | Fee payment procedure |
Free format text: ENTITY STATUS SET TO UNDISCOUNTED (ORIGINAL EVENT CODE: BIG.); ENTITY STATUS OF PATENT OWNER: SMALL ENTITY |
|
| AS | Assignment |
Owner name: THE ROCKEFELLER UNIVERSITY, NEW YORK Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:TRI-INSTITUTIONAL THERAPEUTICS DISCOVERY INSTITUTE, INC.;REEL/FRAME:060735/0477 Effective date: 20220726 Owner name: THE ROCKEFELLER UNIVERSITY, NEW YORK Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:GNEDEVA, KSENIA;HUDSPETH, A. JAMES;KASTAN, NATHANIEL;SIGNING DATES FROM 20220520 TO 20220616;REEL/FRAME:060735/0088 Owner name: TRI-INSTITUTIONAL THERAPEUTICS DISCOVERY INSTITUTE, INC., NEW YORK Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:LIANG, RUI;MEINKE, PETER T.;HUGGINS, DAVID JOHN;AND OTHERS;SIGNING DATES FROM 20220527 TO 20220601;REEL/FRAME:061087/0686 |
|
| FEPP | Fee payment procedure |
Free format text: ENTITY STATUS SET TO SMALL (ORIGINAL EVENT CODE: SMAL); ENTITY STATUS OF PATENT OWNER: SMALL ENTITY |
|
| AS | Assignment |
Owner name: TRI-INSTITUTIONAL THERAPEUTICS DISCOVERY INSTITUTE, INC., NEW YORK Free format text: CORRECTIVE ASSIGNMENT TO CORRECT THE NAME OF INVENTOR ROBERT WALTER MEYERS TO ROBERT WALTER MYERS PREVIOUSLY RECORDED AT REEL: 061087 FRAME: 0686. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT;ASSIGNORS:LIANG, RUI;MEINKE, PETER T.;HUGGINS, DAVID JOHN;AND OTHERS;SIGNING DATES FROM 20220527 TO 20220601;REEL/FRAME:061624/0277 |
|
| STPP | Information on status: patent application and granting procedure in general |
Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION |
|
| STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |
|
| STPP | Information on status: patent application and granting procedure in general |
Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER |
|
| STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |
|
| STPP | Information on status: patent application and granting procedure in general |
Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER |
|
| STPP | Information on status: patent application and granting procedure in general |
Free format text: NOTICE OF ALLOWANCE MAILED -- APPLICATION RECEIVED IN OFFICE OF PUBLICATIONS |
|
| STPP | Information on status: patent application and granting procedure in general |
Free format text: AWAITING TC RESP., ISSUE FEE NOT PAID Free format text: NOTICE OF ALLOWANCE MAILED -- APPLICATION RECEIVED IN OFFICE OF PUBLICATIONS |
|
| STPP | Information on status: patent application and granting procedure in general |
Free format text: PUBLICATIONS -- ISSUE FEE PAYMENT RECEIVED Free format text: PUBLICATIONS -- ISSUE FEE PAYMENT VERIFIED |
|
| STCF | Information on status: patent grant |
Free format text: PATENTED CASE |